mTOR Signaling and Neural Stem Cells: The Tuberous Sclerosis Complex Model

Area of Science:

• Biochemistry
• Cell Biology
• Neuroscience

Background:

• The mechanistic target of rapamycin (mTOR) is a key kinase regulating cell growth, proliferation, and differentiation.
• mTOR signaling is vital for various stem cell compartments, including neural stem cells (NSCs).
• Aberrant mTOR pathway activity is implicated in diseases like cancer and neurological disorders, such as tuberous sclerosis complex (TSC).

Purpose of the Study:

• To review recent findings on the role of mTOR signaling in neurogenesis and tumorigenesis.
• To explore the physiopathology of TSC and its connection to mTOR hyperactivation in NSCs.
• To discuss the therapeutic potential of targeting mTOR for neurological diseases and cancer.

Main Methods:

• Literature review of recent contributions in TSC physiopathology.
• Analysis of studies investigating mTOR signaling in neurogenesis.
• Examination of research on mTOR's role in tumorigenesis.

Main Results:

• Hyperactivation of mTORC1 in NSCs contributes to neurological symptoms in TSC.
• mTOR signaling is a critical regulator of both neural stem cell behavior and tumor development.
• Understanding mTOR's dual role provides insights into disease mechanisms.

Conclusions:

• Targeting the mTOR pathway holds promise for novel therapeutic strategies.
• Further research into mTOR signaling in neurogenesis and tumorigenesis is warranted.
• Insights from TSC studies can advance treatments for neurological disorders and cancer.